The Psychiatrická nemocnice Bohnice is seeking suppliers for the procurement of Atomoxetine, a medication used in the treatment of attention deficit hyperactivity disorder (ADHD). This contract, valued at approximately €191,375.66, aims to ensure the availability of this essential pharmaceutical pro
Contract awarded. Originally published 11 months ago.
This contract opportunity is for the procurement of the active ingredient Apixaban, which is a medication used in the healthcare sector. The buyer is the Psychiatric Hospital Bohnice in the Czech Republic, and the total value of the contract is approximately €265,211.32. Suppliers interested in this
This contract involves the supply of the active ingredient Levetiracetam to the Psychiatric Hospital Bohnice. Suppliers are invited to provide this essential medication, which is used in the treatment of epilepsy and other neurological conditions. The total value of the contract is €146,732. Interes
This contract involves the supply of the active ingredient Metamizole to Bohnice Psychiatric Hospital. The hospital is seeking a reliable supplier to provide this essential medication, which is used for its analgesic and antipyretic properties. The total value of the contract is approximately €111,7
This public procurement contract involves the delivery, transportation, implementation, installation, and ongoing support of a comprehensive integration solution for the Psychiatric Hospital Bohnice. The solution includes a malware protection system (EDR), a telemetric network traffic monitoring sys
Supply non-clinical consumables including forms, labels, and packaging for pathology and primary care services.
Procurement of RSV immunisation vaccine products for adult populations, scheduled for 2028.
Procurement for meningococcal ACWY vaccine supply in 2027 from qualified manufacturers or distributors.
Procurement opportunity for MMR vaccine supply with anticipated delivery timeline of 2027.
